–Joining forces for single-cell research excellence– PLEASANTON, CA.—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced that it has joined the Corporate Partnership Program of the European Molecular Biology Laboratory (EMBL), one of the world’s leading research institutions. “As a leader in single cell genomics, 10x Genomics is investing in institutional training […]
DARMSTADT, GERMANY Investment supports growing demand for biopharmaceutical research Builds capabilities with two new manufacturing and distribution centers in South Korea and India Accelerates Mobius® single-use manufacturing in China for biosimilars development Darmstadt, Germany – Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced an additional investment of $47 million to build a robust […]
ATUM licenses Company’s Leap-In Transposase® Technology to Just NEWARK, Calif.–Dedicated to creating technologies and tools to improve peoples’ lives, ATUM today announced a patent licensing agreement giving Just Biotherapeutics access to the company’s Leap-In cell line development tools. “We love everything about Just’s mission, and we are delighted that our Leap-In technology will be used to help democratize access […]
Designed for the Immunotherapy market, the HANABI-L 2.0 Automated Lymphocyte Isolator enables increased throughput for higher productivity in providing high-quality sample preparation. Omaha – Nebraska: ADS Biotec, a global leader in development of automated instruments and consumables for use in cytogenetic, pathology and research laboratories has launched its newest system, the HANABI-L 2.0 Automated Lymphocyte Isolator. […]
CE-IVD labeled PAXgene® Blood ccfDNA tube will be available in Western Europe FRANKLIN LAKES, N.J. and EYSINS, Switzerland — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial availability of the CE-IVD marked PAXgene® Blood ccfDNA tube within the European Economic Area and Switzerland (Western Europe). The plastic blood collection tube, which includes […]
Real Endpoints plays 3rd party role introducing parties, helping craft structure, and will provide all analytics and financial reconciliation SAN DIEGO, WELLESLEY, Mass. and WESTPORT, Conn. — Illumina, Inc. and Harvard Pilgrim Health Care announced on February 1 a major new value-based contract (VBC) – one of the first of its kind between a […]
Patents in South Korea and Israel cover integration of an external DNA sequence into the chromosome of eukaryotic cells Merck continues to support research with genome editing under careful ethical and legal standards Merck to license its CRISPR-related patents to interested parties Darmstadt, Germany – Merck, a leading science and technology company and leader in genome editing, […]
Fleet to provide support for Gyrolab platform users in developing, transferring and optimizing assays Uppsala, Sweden, and Hampshire, UK: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, and Fleet Bioprocessing Ltd. (Fleet), an expert provider of contract immunoassay development services and immunoassay reagent manufacture, announced today […]
Illumina and Genomics England partnership sequences 50,000 genomes The United Kingdom’s pioneering 100,000 Genomes Project has reached a major milestone by sequencing 50,000 genomes. Of those 50,000 genomes sequenced so far, 8,000 are for cancer patients and 42,000 for rare diseases. Breast, brain, colorectal, lung, prostate and renal are among those cancers to have […]
GenomeNext and Genomenon Partner to Speed Variant Curation for Whole Exome and Whole Genome Analysis ANN ARBOR, MI — GenomeNext, LLC announced today that it has embedded Genomenon’s Mastermind search results in its Olympus Platform to simplify and accelerate variant curation for genomic analysis. Efficacious variant interpretation is a critical but challenging requirement to translate genomics […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
